# Lumos Pharma, Inc.: Form D filings

Lumos Pharma, Inc., a pharmaceuticals company in Austin, TX, filed 3 Form D notices with the SEC between 2014 and 2016. The latest, on April 18, 2016, reports $34 million sold of a $34 million offering to 6 investors.

Find out what Lumos Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Lumos%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Lumos%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Flumos-pharma-inc-1596584)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Lumos%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Lumos%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Flumos-pharma-inc-1596584)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 4200 Marathon Blvd., Suite 200, Austin, TX, 78756
- Phone: (512) 215-2630
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2014
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1596584

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 18, 2016 | New notice | $33,999,991 | $33,999,991 | $0 | 6 | Apr 4, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1596584/000159658416000002/0001596584-16-000002-index.htm) |
| May 1, 2015 | Amendment | $13,000,000 | $13,000,000 | $0 | 5 | Jan 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1596584/000159658415000001/0001596584-15-000001-index.htm) |
| Feb 6, 2014 | New notice | $7,500,000 | $6,500,000 | $1,000,000 | 3 | Jan 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1596584/000159658414000001/0001596584-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Michele Gilbert Park | Director |  |
| G. Gilbert Cloyd | Director |  |
| Kevin S. Lelande | Director |  |
| Robert S. Heft | Director |  |
| Cameron Gilbert Wheeler | Director |  |
| Richard John Hawkins | Executive Officer, Director |  |
| Edward Gilbert Mathers | Director |  |
| Jon S. Saxe | Director |  |
| Tracy Gilbert Saxton | Director |  |

## Other pharmaceuticals companies in Texas that filed recently

- [LUCIER PHARMACEUTICALS INC](https://specstream.ai/data/form-d/company/lucier-pharmaceuticals-inc-2158290) offering · Oct 13, 2026
- [FibroBiologics, Inc.](https://specstream.ai/data/form-d/company/fibrobiologics-inc-1958777) $1.2 million · Oct 13, 2026
- [Eos SENOLYTIX, Inc.](https://specstream.ai/data/form-d/company/eos-senolytix-inc-2129803) $750,000 · Aug 27, 2026

[Every Form D from the week of Apr 18, 2016](https://specstream.ai/data/form-d/week/2016-04-18) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Lumos Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).